Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,3.14039053816451e-70,100.52062328139321,16086.979718917308,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",1.2875601206474491e-67,0,0,76
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,8.998016351074766e-50,42.4205545509343,4790.6486929839,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'COX11', 'NDUFV2', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",1.844593351970327e-47,0,0,61
3,Oxidative phosphorylation WP623,1.5104242693350688e-27,32.43936716993254,2003.3711987486956,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB6', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'NDUFV2', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",2.064246501424594e-25,0,0,35
4,Nonalcoholic fatty liver disease WP4396,5.484196023820125e-25,9.21594982078853,514.8283636958375,"['NDUFA13', 'COX7B', 'NDUFA11', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'CYC1', 'NDUFV2', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'COX6C', 'EIF2S1', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",5.621300924415628e-23,0,0,51
5,Mitochondrial complex I assembly model OXPHOS system WP4324,1.8361047171829246e-23,30.45382585751979,1594.3129298184836,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFB6', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'NDUFV2', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'NDUFAF3', 'TMEM126B']",1.5056058680899982e-21,0,0,30
6,Mitochondrial CIV Assembly WP4922,1.8833597482373098e-14,20.125544899738447,636.0302926901911,"['COX8A', 'COA3', 'COX7B', 'COX16', 'PET100', 'NDUFA4', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'COX11', 'COX14', 'SMIM20']",1.2869624946288283e-12,0,0,20
7,Mitochondrial complex III assembly WP4921,7.627007101159964e-08,29.919689119170986,490.35334305176514,"['UQCRB', 'UQCC3', 'UQCRQ', 'LYRM7', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",4.467247016393693e-06,0,0,9
8,Cellular Proteostasis WP4918,5.89638724527323e-07,inf,inf,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",3.0218984632025305e-05,0,0,6
9,Proteasome Degradation WP183,8.141525887899762e-05,4.326574234546505,40.738797348695975,"['H2AFZ', 'HLA-B', 'PSMB10', 'PSMA7', 'PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'PSMB5', 'PSMD4', 'PSMA2', 'PSMB1', 'PSME1']",0.0037089173489321136,0,0,13
10,mRNA Processing WP411,0.00019517856829611674,3.263320271636022,27.873962346338875,"['SF3B5', 'DHX8', 'RNMT', 'SNU13', 'LSM2', 'PRPF4', 'LSM7', 'PHF5A', 'SNRPD1', 'SNRPG', 'SRSF3', 'SNRPE', 'SNRPB2', 'DNAJC8', 'HNRNPA1', 'SRSF9']",0.008002321300140787,0,0,16
11,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.00032688582958527093,39.72828890799656,318.85525777852735,"['UBA3', 'ELOB', 'ELOC', 'RBX1']",0.011440672637562628,0,0,4
12,Cholesterol Biosynthesis Pathway WP197,0.0003348489552457355,9.944875107665805,79.57721000402097,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'PMVK', 'FDFT1']",0.011440672637562628,0,0,6
13,Pyrimidine metabolism WP4022,0.001211256152397489,2.9100896212778258,19.544445093018396,"['POLR3GL', 'NME2', 'NME1', 'POLE4', 'POLD4', 'POLD2', 'POLE3', 'POLR3H', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'POLR2L']",0.03820115557561311,0,0,14
14,Base Excision Repair WP4752,0.002669897213900499,4.64132183908046,27.50315185252396,"['POLE4', 'POLD4', 'NEIL2', 'TDG', 'APEX1', 'POLD2', 'POLE3']",0.07818984697851461,0,0,7
15,VEGFA-VEGFR2 Signaling Pathway WP3888,0.0041301869966301405,1.6327638219290084,8.962946944686621,"['RPL5', 'SET', 'NOTCH4', 'CLTC', 'ARPC5L', 'TXN', 'RPL10A', 'RPL7', 'ICAM1', 'ACTG1', 'LDHA', 'PAK1', 'PSMD4', 'RPL18A', 'CCND1', 'TMSB4X', 'RACK1', 'AP2S1', 'PGK1', 'RPLP2', 'ELOC', 'ATP6V1E1', 'RPS11', 'CCT7', 'TMSB10', 'ACP1', 'HRAS', 'SLC25A25', 'PTPN1', 'SDF2L1', 'SSR4', 'TPM3', 'RPS6', 'SARS', 'RPL13A', 'TFCP2', 'PTPN9', 'CYCS', 'RPL27', 'RPL26', 'PTMA']",0.10755870762648019,0,0,41
16,Selenium Micronutrient Network WP15,0.0041974129805455685,2.7173553719008265,14.872865560987965,"['SERPINA3', 'SELENOM', 'PRDX5', 'GPX4', 'PRDX1', 'SELENOW', 'TXN', 'SEPHS2', 'ICAM1', 'SELENOH', 'SOD1', 'MSRB1']",0.10755870762648019,0,0,12
17,Nucleotide Excision Repair WP4753,0.004585333019653957,3.617538630480822,19.480056797061447,"['POLE4', 'POLD4', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'GTF2H5', 'RBX1']",0.11058744341518366,0,0,8
18,Fatty acid transporters WP5061,0.006094280744169769,7.942906276870163,40.51203516013689,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.13881417250608918,0,0,4
19,Dual hijack model of Vif in HIV infection WP3300,0.00668668578658871,14.8840206185567,74.53377125252051,"['ELOB', 'ELOC', 'RBX1']",0.1442916406579669,0,0,3
20,Glycolysis and Gluconeogenesis WP534,0.008504100962819571,3.1826056945642796,15.172139399431394,"['LDHA', 'TPI1', 'PDHA1', 'GOT1', 'MPC2', 'PGK1', 'DLD', 'PFKM']",0.1649780567637752,0,0,8
21,DNA Mismatch Repair WP531,0.008852481094641595,4.966437177280551,23.476634154701014,"['POLE4', 'POLD4', 'POLD2', 'POLE3', 'RPA2']",0.1649780567637752,0,0,5
22,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.008852481094641595,4.966437177280551,23.476634154701014,"['EIF5', 'EIF3I', 'EIF3J', 'EIF2S1', 'EIF1']",0.1649780567637752,0,0,5
23,Computational Model of Aerobic Glycolysis WP4629,0.009426319243637727,6.618515333906563,30.870407383893838,"['LDHA', 'TPI1', 'PGK1', 'PFKM']",0.16803438651702035,0,0,4
24,Ciliary landscape WP4352,0.013782328444435292,1.7707846175517679,7.586693047591809,"['POM121', 'NUDC', 'NDUFA5', 'TRAF3IP1', 'SSNA1', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'LSM4', 'PSMD8', 'COPS4', 'MYL6', 'COPS6', 'IFT22', 'PSMD7', 'RAB14', 'RANBP10', 'NEFL', 'SNRPB2', 'DCAF11', 'CALM2']",0.23544811092576956,0,0,22
25,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.016698860845929128,3.0248500749625187,12.378941138043057,"['MAP4K1', 'LATS1', 'PAK1', 'YWHAQ', 'LIMD1', 'ACTG1', 'PAK4']",0.2738613178732377,0,0,7
26,Aflatoxin B1 metabolism WP699,0.02369449465992628,19.830042918454936,74.21418450235134,"['AKR7A2', 'AKR7A3']",0.37188197359662034,0,0,2
27,7q11.23 copy number variation syndrome WP4932,0.02448978850514329,2.058934169278997,7.637614332647484,"['ATP5PB', 'CLTC', 'ATP5MC2', 'EIF4H', 'ATP5PO', 'ATP5MC3', 'SQSTM1', 'DLD', 'ATP5F1D', 'VAMP2', 'ATP5F1E', 'ATP5MC1']",0.37188197359662034,0,0,12
28,Ferroptosis WP4313,0.02741242731459713,2.97984496124031,10.717783636990253,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'VDAC2', 'FTL']",0.4013962571066008,0,0,6
29,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.030349919008889222,5.952061855670103,20.802226614842183,"['IDI1', 'HMGCS1', 'PMVK']",0.4290850618498131,0,0,3
30,Eukaryotic Transcription Initiation WP405,0.03259553200197054,2.8377014888642798,9.715098219764132,"['GTF2A2', 'POLR3H', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.44205979860464745,0,0,6
31,Unfolded protein response WP4925,0.03342403355303432,3.9697334479793636,13.491060007392537,"['XBP1', 'DDIT3', 'TNFRSF10B', 'EIF2S1']",0.44205979860464745,0,0,4
32,Translation Factors WP107,0.034800094273838775,2.3383241130792265,7.85240847382594,"['EEF1B2', 'EIF5', 'EIF1AY', 'EIF3I', 'EIF3J', 'EIF4H', 'EIF2S1', 'EIF1']",0.4458762078835593,0,0,8
33,Cytosolic DNA-sensing pathway WP4655,0.037015573373792,2.4836206896551722,8.187048352499085,"['IRF3', 'POLR3GL', 'POLR3H', 'IKBKG', 'POLR3K', 'POLR2K', 'POLR2L']",0.4598904570683248,0,0,7
34,Melanoma WP4685,0.04055098783308104,2.129903774981495,6.82675722366396,"['PAK1', 'CCND1', 'BAD', 'GADD45A', 'BAX', 'KRAS', 'CALM3', 'HRAS', 'CALM2']",0.4889972062224478,0,0,9
35,Mevalonate pathway WP3963,0.04451824170719664,9.914163090128755,30.851450353747467,"['HMGCS1', 'PMVK']",0.521499402855732,0,0,2
36,DNA damage response WP707,0.04993773215321087,2.148170603735746,6.43802091306988,"['CCNB1', 'CCND1', 'GADD45A', 'SESN1', 'RPA2', 'TNFRSF10B', 'CYCS', 'BAX']",0.5687352828560127,0,0,8
37,Synaptic Vesicle Pathway WP2267,0.05479468992557669,2.242686318131257,6.513124358123834,"['RAB3A', 'CLTC', 'AP2S1', 'PARK7', 'SLC25A4', 'AP2M1', 'VAMP2']",0.6020495292565775,0,0,7
38,miRNA regulation of DNA damage response WP1530,0.0557997124676828,2.091458153580673,6.03592012730056,"['CCNB1', 'CCND1', 'GADD45A', 'SESN1', 'RPA2', 'TNFRSF10B', 'CYCS', 'BAX']",0.6020495292565775,0,0,8
39,CAMKK2  Pathway WP4874,0.06307431776373058,2.6118760757314976,7.217767003769229,"['FIS1', 'MAP1LC3A', 'SQSTM1', 'CALM2', 'ICAM1']",0.6630889816187061,0,0,5
40,DNA Repair Pathways Full Network WP4946,0.0650540471131323,1.7290419725202333,4.7246709233288335,"['POLE4', 'POLD4', 'NEIL2', 'CENPX', 'TDG', 'APEX1', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'GTF2H5', 'RBX1']",0.6668039829096061,0,0,12
41,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.06771999314659738,2.2909958258795466,6.16821719001537,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'PMVK', 'FDFT1']",0.6771999314659738,0,0,6
42,Peroxiredoxin 2 induced ovarian failure WP4873,0.06973931922865724,6.608869814020029,17.59936083057426,"['STAR', 'BAX']",0.6776848900391697,0,0,2
43,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.07272715893103283,3.7190721649484537,9.747838353236764,"['LDHA', 'PDHA1', 'RPS6']",0.6776848900391697,0,0,3
44,RalA downstream regulated genes WP2290,0.07272715893103283,3.7190721649484537,9.747838353236764,"['RAC3', 'KRAS', 'HRAS']",0.6776848900391697,0,0,3
45,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.07664224393574237,2.2059527227485884,5.666225311570038,"['XBP1', 'MAP1LC3A', 'PPP1R11', 'PPP1R7', 'DDIT3', 'EIF2S1']",0.6982960003034304,0,0,6
46,Leptin signaling pathway WP2034,0.08348083213185135,1.8916142816056534,4.697139736769441,"['PTPN1', 'CCND1', 'BAD', 'CFL2', 'RPS6', 'BAX', 'IKBKG', 'HRAS']",0.7333549414371169,0,0,8
47,Copper homeostasis WP3286,0.08619539526078565,2.126984126984127,5.213532729307331,"['CCND1', 'COX17', 'COX11', 'MT3', 'ATOX1', 'SOD1']",0.7333549414371169,0,0,6
48,Cori Cycle WP1946,0.09058530658913778,3.3055555555555554,7.938170213988959,"['LDHA', 'TPI1', 'PGK1']",0.7333549414371169,0,0,3
49,TP53 network WP1742,0.09058530658913778,3.3055555555555554,7.938170213988959,"['SUMO1', 'GADD45A', 'BAX']",0.7333549414371169,0,0,3
50,Mitochondrial CII Assembly WP4920,0.0917522466351797,inf,inf,['SDHAF1'],0.7333549414371169,0,0,1
51,Androgen receptor signaling pathway WP138,0.09527612024287656,1.752666869856751,4.12047787724686,"['CCND1', 'SUMO1', 'PRDX1', 'BAG1', 'RACK1', 'DSTN', 'STUB1', 'PARK7', 'RAN']",0.7333549414371169,0,0,9
52,Amyotrophic lateral sclerosis (ALS) WP2447,0.09571928495388243,2.2551243936786105,5.291278390581821,"['BAD', 'NEFL', 'BAX', 'NEFH', 'SOD1']",0.7333549414371169,0,0,5
53,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.09637053634257926,2.053461641272387,4.804185964878589,"['PAK1', 'PTPRC', 'RRAS', 'CHP1', 'IKBKG', 'CALM2']",0.7333549414371169,0,0,6
54,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.09837688238790593,4.956223175965666,11.493230946564106,"['COX8A', 'COX5A']",0.7333549414371169,0,0,2
55,TCA cycle in senescence WP5050,0.09837688238790593,4.956223175965666,11.493230946564106,"['PDHA1', 'GOT1']",0.7333549414371169,0,0,2
56,Hippo-Yap signaling pathway WP4537,0.11005205625370285,2.974742268041237,6.564666551376825,"['MAP4K1', 'LATS1', 'YWHAQ']",0.8057382690003244,0,0,3
57,Modulators of TCR signaling and T cell activation WP5072,0.11853236190372309,1.92064682837376,4.095912384463446,"['MAP4K1', 'NDUFB10', 'ELOB', 'IKBKG', 'RNF7', 'MEF2D']",0.852601199658359,0,0,6
58,Trans-sulfuration pathway WP2333,0.12959280565078293,3.9646351931330472,8.101169072901858,"['AHCY', 'GOT1']",0.9099958297524808,0,0,2
59,Nanomaterial induced apoptosis WP2507,0.13095061940340577,2.7040768509840674,5.497212413468143,"['ENDOG', 'BAX', 'CYCS']",0.9099958297524808,0,0,3
60,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.15309849455252247,2.4785223367697595,4.651377955592225,"['RRAS', 'KRAS', 'HRAS']",0.9997651170634212,0,0,3
61,Glycolysis in senescence WP5049,0.16267378478166744,3.303576537911302,5.999322755611252,"['LDHA', 'PGK1']",0.9997651170634212,0,0,2
62,HIF1A and PPARG regulation of glycolysis WP2456,0.16267378478166744,3.303576537911302,5.999322755611252,"['LDHA', 'TPI1']",0.9997651170634212,0,0,2
63,Senescence and Autophagy in Cancer WP615,0.1681983865926208,1.5139632914727321,2.6988078042306025,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3B', 'RNASEL', 'MAP1LC3A', 'SQSTM1', 'ING1', 'HRAS', 'GABARAP']",0.9997651170634212,0,0,9
64,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.1695367199596448,1.7005537098560355,3.0179484167646216,"['PAK1', 'TMSB4X', 'NEFL', 'NEFH', 'PFN2', 'SOD1']",0.9997651170634212,0,0,6
65,MET in type 1 papillary renal cell carcinoma WP4205,0.1695367199596448,1.7005537098560355,3.0179484167646216,"['PAK1', 'BAD', 'RPL11', 'KRAS', 'HRAS', 'PAK4']",0.9997651170634212,0,0,6
66,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.17071082345144584,1.6151363271852446,2.8552125525880476,"['CCND1', 'BAD', 'GADD45A', 'RAC3', 'CYCS', 'BAX', 'KRAS']",0.9997651170634212,0,0,7
67,GABA metabolism (aka GHB) WP4157,0.1750926776786282,9.906518010291595,17.2615118401314,['AKR7A2'],0.9997651170634212,0,0,1
68,miRNA Biogenesis WP2338,0.1750926776786282,9.906518010291595,17.2615118401314,['RAN'],0.9997651170634212,0,0,1
69,Imatinib and Chronic Myeloid Leukemia WP3640,0.17631224756520616,2.28766851704996,3.970245787625229,"['BCR', 'SPRED2', 'GADD45A']",0.9997651170634212,0,0,3
70,Methionine De Novo and Salvage Pathway WP3580,0.17631224756520616,2.28766851704996,3.970245787625229,"['AHCY', 'ODC1', 'TXN']",0.9997651170634212,0,0,3
71,Photodynamic therapy-induced unfolded protein response WP3613,0.17631224756520616,2.28766851704996,3.970245787625229,"['NARS', 'XBP1', 'DDIT3']",0.9997651170634212,0,0,3
72,Non-small cell lung cancer WP4255,0.18331767254213738,1.5782915360501568,2.6776263821991892,"['CCND1', 'BAD', 'GADD45A', 'CYCS', 'BAX', 'KRAS', 'HRAS']",0.9997651170634212,0,0,7
73,miRNA regulation of prostate cancer signaling pathways WP3981,0.1919824288052031,1.8885476804651353,3.1167673608896918,"['CCND1', 'BAD', 'KRAS', 'IKBKG']",0.9997651170634212,0,0,4
74,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.1919824288052031,1.8885476804651353,3.1167673608896918,"['LDHA', 'PDHA1', 'PGK1', 'BAX']",0.9997651170634212,0,0,4
75,Galanin receptor pathway WP4970,0.1970155175416057,2.8313917841814837,4.599518894525896,"['POMC', 'VAMP2']",0.9997651170634212,0,0,2
76,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.1970155175416057,2.8313917841814837,4.599518894525896,"['IDH3B', 'DLD']",0.9997651170634212,0,0,2
77,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.1970155175416057,2.8313917841814837,4.599518894525896,"['PDHA1', 'DLD']",0.9997651170634212,0,0,2
78,GABA receptor Signaling WP4159,0.20041125920313868,2.124079528718704,3.414210870805833,"['GABRB3', 'AP2S1', 'AP2M1']",0.9997651170634212,0,0,3
79,SARS-CoV-2 mitochondrial interactions WP5038,0.20041125920313868,2.124079528718704,3.414210870805833,"['NDUFB9', 'IRF3', 'PHB']",0.9997651170634212,0,0,3
80,Statin inhibition of cholesterol production WP430,0.20041125920313868,2.124079528718704,3.414210870805833,"['SQLE', 'APOC1', 'FDFT1']",0.9997651170634212,0,0,3
81,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.20548272680640867,1.4697216629917234,2.325677716863633,"['SHC3', 'CCND1', 'RRAS', 'BAD', 'RPS6', 'BAX', 'KRAS', 'HRAS']",0.9997651170634212,0,0,8
82,Fas ligand pathway and stress induction of heat shock proteins WP314,0.21161020108658618,1.802548268584382,2.7993743525500774,"['PAK1', 'ARHGDIB', 'CYCS', 'ACTG1']",0.9997651170634212,0,0,4
83,Pancreatic adenocarcinoma pathway WP4263,0.21224352658852783,1.417345176412534,2.1969147214269107,"['PAK1', 'CCND1', 'BAD', 'GADD45A', 'RAC3', 'BAX', 'KRAS', 'IKBKG', 'PAK4']",0.9997651170634212,0,0,9
84,Pathogenic Escherichia coli infection WP2272,0.2127904093275162,1.565891472868217,2.4231349882088753,"['TUBA1A', 'YWHAQ', 'ARPC2', 'ARPC3', 'ARPC5L', 'ACTG1']",0.9997651170634212,0,0,6
85,Myometrial relaxation and contraction pathways WP289,0.21408290678281394,1.3381584707427403,2.0626266599863805,"['RGS4', 'CNN1', 'GNG3', 'YWHAQ', 'PRKAR1A', 'GSTO1', 'CRH', 'CALM3', 'IGFBP6', 'CALM2', 'ACTG1', 'YWHAH']",0.9997651170634212,0,0,12
86,G Protein Signaling Pathways WP35,0.21791056235829973,1.4428739508981097,2.1984645676799097,"['GNG3', 'PDE1C', 'RRAS', 'PRKAR1A', 'GNA12', 'KRAS', 'HRAS', 'CALM2']",0.9997651170634212,0,0,8
87,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.22799124232065418,1.5256078977009209,2.2555320391782,"['PAK1', 'BAD', 'BAX', 'KRAS', 'IKBKG', 'HRAS']",0.9997651170634212,0,0,6
88,Folate Metabolism WP176,0.23133724206651132,1.5991616234523347,2.3409786556123997,"['SERPINA3', 'AHCY', 'GPX4', 'ICAM1', 'SOD1']",0.9997651170634212,0,0,5
89,Metabolic reprogramming in colon cancer WP4290,0.23176514449642446,1.72402706643239,2.5205805474604124,"['LDHA', 'PDHA1', 'PGK1', 'PYCR2']",0.9997651170634212,0,0,4
90,Cysteine and methionine catabolism WP4504,0.23210873276147584,2.4772532188841203,3.6181505573568162,"['AHCY', 'GOT1']",0.9997651170634212,0,0,2
91,Homologous recombination WP186,0.23210873276147584,2.4772532188841203,3.6181505573568162,"['POLD4', 'POLD2']",0.9997651170634212,0,0,2
92,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.23210873276147584,2.4772532188841203,3.6181505573568162,"['RRAS', 'IKBKG']",0.9997651170634212,0,0,2
93,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.23210873276147584,2.4772532188841203,3.6181505573568162,"['RNASEL', 'IRF3']",0.9997651170634212,0,0,2
94,Integrated breast cancer pathway WP1984,0.24220992435263045,1.3148684704214784,1.8644183693635958,"['PAK1', 'CCND1', 'RRAS', 'GADD45A', 'BAD', 'ODC1', 'BAX', 'KRAS', 'PHB', 'FAU', 'CCNB1IP1']",0.9997651170634212,0,0,11
95,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.24352565136200596,1.4873385012919897,2.100914711683802,"['PSMD8', 'PSMC5', 'TUBA1A', 'PSMD7', 'PSMD4', 'STUB1']",0.9997651170634212,0,0,6
96,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.24896300477550787,1.549053356282272,2.1538827398952205,"['BEX3', 'SERBP1', 'TNFRSF10B', 'RNF7', 'SQSTM1']",0.9997651170634212,0,0,5
97,Canonical and non-canonical Notch signaling WP3845,0.25057323013337707,1.8582474226804124,2.5718219873549653,"['RRAS', 'NOTCH4', 'DLL3']",0.9997651170634212,0,0,3
98,Gastric acid production WP2596,0.2507917892635066,4.952830188679245,6.850418959387811,['CCK'],0.9997651170634212,0,0,1
99,MED and Pseudoachondroplasia genes WP4789,0.2507917892635066,4.952830188679245,6.850418959387811,['COL9A3'],0.9997651170634212,0,0,1
100,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.2507917892635066,4.952830188679245,6.850418959387811,['MAS1'],0.9997651170634212,0,0,1
101,The alternative pathway of fetal androgen synthesis WP4524,0.2507917892635066,4.952830188679245,6.850418959387811,['STAR'],0.9997651170634212,0,0,1
102,Bladder cancer WP2828,0.2523617527211815,1.6520492977930639,2.2746929565117147,"['CCND1', 'DAPK1', 'KRAS', 'HRAS']",0.9997651170634212,0,0,4
103,p53 transcriptional gene network WP4963,0.2669144928924724,1.5019819537891828,1.9838582027438456,"['SIVA1', 'GADD45A', 'SESN1', 'BAX', 'ICAM1']",0.9997651170634212,0,0,5
104,PPAR-alpha pathway WP2878,0.2675268620988176,2.2018121125417265,2.9031669913301603,"['CCND1', 'DBI']",0.9997651170634212,0,0,2
105,NO/cGMP/PKG mediated Neuroprotection WP4008,0.27331599097527076,1.585829750644884,2.0570220748309933,"['BAD', 'NEFL', 'CYCS', 'CALM2']",0.9997651170634212,0,0,4
106,Endometrial cancer WP4155,0.27545153238329917,1.4162667651039744,1.8260544779785732,"['CCND1', 'BAD', 'GADD45A', 'BAX', 'KRAS', 'HRAS']",0.9997651170634212,0,0,6
107,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.2763114863136707,1.7487871437234688,2.2493363251895686,"['BAD', 'KRAS', 'HRAS']",0.9997651170634212,0,0,3
108,DNA Replication WP466,0.29454605070615075,1.5247040148157947,1.86367608787919,"['POLD4', 'POLD2', 'RPA2', 'UBA52']",0.9997651170634212,0,0,4
109,Alzheimer's disease WP2059,0.2955219805399339,1.334549071618037,1.6268314138616204,"['PSENEN', 'ATP5MD', 'BAD', 'CHP1', 'CYCS', 'CALM3', 'CALM2']",0.9997651170634212,0,0,7
110,ErbB signaling pathway WP673,0.2955219805399339,1.334549071618037,1.6268314138616204,"['PAK1', 'SHC3', 'CCND1', 'BAD', 'KRAS', 'HRAS', 'PAK4']",0.9997651170634212,0,0,7
111,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.3022882296529249,1.6514891179839633,1.975799160500523,"['PTPN1', 'CCND1', 'TPM3']",0.9997651170634212,0,0,3
112,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.3029151713458859,1.9814592274678111,2.366461659921097,"['BAD', 'BAX']",0.9997651170634212,0,0,2
113,Notch Signaling Pathway Netpath WP61,0.30358623750430846,1.4159085320875338,1.6878897868062652,"['PSENEN', 'CCND1', 'NOTCH4', 'SKP1', 'DLL3']",0.9997651170634212,0,0,5
114,Ras signaling WP4223,0.30641561074268026,1.2049514893341324,1.425232157643869,"['SHC3', 'RASA4B', 'BAD', 'GNG3', 'PAK1', 'RRAS', 'RAC3', 'CALM3', 'KRAS', 'IKBKG', 'CALM2', 'HRAS', 'PAK4']",0.9997651170634212,0,0,13
115,Aryl Hydrocarbon Receptor Netpath WP2586,0.3159729801591868,1.4681061112703417,1.691402958561916,"['KLF6', 'AIP', 'KRAS', 'HRAS']",0.9997651170634212,0,0,4
116,Cell Differentiation - Index WP2029,0.31954963701066186,3.301600914808462,3.766607166031078,['MEF2D'],0.9997651170634212,0,0,1
117,Glucuronidation WP698,0.31954963701066186,3.301600914808462,3.766607166031078,['UGP2'],0.9997651170634212,0,0,1
118,Regulation of Actin Cytoskeleton WP51,0.32118829439008695,1.2118608227604768,1.3763439545698128,"['PAK1', 'RRAS', 'CFL2', 'TMSB4X', 'GNA12', 'BRK1', 'RAC3', 'KRAS', 'ACTG1', 'SSH1', 'PAK4']",0.9997651170634212,0,0,11
119,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.32298752617241816,1.224004182805681,1.3832980151663288,"['GABRB3', 'RAB3A', 'SHC3', 'BAD', 'RPS6', 'RACK1', 'IKBKG', 'SQSTM1', 'EIF2S1', 'HRAS']",0.9997651170634212,0,0,10
120,Endothelin Pathways WP2197,0.32836747586703674,1.5644329896907216,1.7421869079758063,"['CNN1', 'RIIAD1', 'CALM2']",0.9997651170634212,0,0,3
121,Glycosylation and related congenital defects WP4521,0.32836747586703674,1.5644329896907216,1.7421869079758063,"['DPM2', 'DPM3', 'MAGT1']",0.9997651170634212,0,0,3
122,Signaling of Hepatocyte Growth Factor Receptor WP313,0.32836747586703674,1.5644329896907216,1.7421869079758063,"['MAP4K1', 'PAK1', 'HRAS']",0.9997651170634212,0,0,3
123,Hippo-Merlin Signaling Dysregulation WP4541,0.33768301639707793,1.222123642558024,1.326795654245274,"['LATS1', 'PAK1', 'CCND1', 'PRKAR1A', 'KRAS', 'ITGAE', 'HRAS', 'RBX1', 'PAK4']",0.9997651170634212,0,0,9
124,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.3379811873088024,1.801170503316426,1.9538468000975135,"['CD63', 'SOD1']",0.9997651170634212,0,0,2
125,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.3379811873088024,1.801170503316426,1.9538468000975135,"['LDHA', 'PDHA1']",0.9997651170634212,0,0,2
126,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.3379811873088024,1.801170503316426,1.9538468000975135,"['KRAS', 'HRAS']",0.9997651170634212,0,0,2
127,BDNF-TrkB Signaling WP3676,0.3544247451041124,1.4860824742268042,1.5414527780318203,"['HOMER1', 'KRAS', 'HRAS']",0.9997651170634212,0,0,3
128,miRNA regulation of p53 pathway in prostate cancer WP3982,0.37248627427906567,1.6509298998569384,1.6303842248701077,"['TNFRSF10B', 'BAX']",0.9997651170634212,0,0,2
129,Nucleotide metabolism WP404,0.37248627427906567,1.6509298998569384,1.6303842248701077,"['NME2', 'OAZ1']",0.9997651170634212,0,0,2
130,Serotonin and anxiety WP3947,0.37248627427906567,1.6509298998569384,1.6303842248701077,"['POMC', 'CRH']",0.9997651170634212,0,0,2
131,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.37248627427906567,1.6509298998569384,1.6303842248701077,"['IRF3', 'IKBKG']",0.9997651170634212,0,0,2
132,Apoptosis WP254,0.3754955822492455,1.2385874246339363,1.2132070006273707,"['IRF3', 'BAD', 'TNFRSF10B', 'CYCS', 'BAX', 'IKBKG']",0.9997651170634212,0,0,6
133,IL-18 signaling pathway WP4754,0.37752274289351595,1.1169711579642931,1.0880689328253805,"['NRN1', 'IMP3', 'BAD', 'COX17', 'NDUFC1', 'BPGM', 'RND2', 'ICAM1', 'PTMS', 'NACA', 'TMSB4X', 'CYCS', 'BAX', 'RPS11', 'AARS', 'ITM2C']",0.9997651170634212,0,0,16
134,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.3785999501899282,1.2702458184385894,1.2337582254950414,"['IDI1', 'SQLE', 'HMGCS1', 'DBI', 'FDFT1']",0.9997651170634212,0,0,5
135,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.3785999501899282,1.2702458184385894,1.2337582254950414,"['APEX1', 'RPS6', 'GNA12', 'HRAS', 'MYL12B']",0.9997651170634212,0,0,5
136,MAPK Cascade WP422,0.3803471426204138,1.415193912616593,1.368026787431211,"['RRAS', 'KRAS', 'HRAS']",0.9997651170634212,0,0,3
137,Parkinson's disease pathway WP2371,0.3803471426204138,1.415193912616593,1.368026787431211,"['PINK1', 'CYCS', 'PARK7']",0.9997651170634212,0,0,3
138,Type 2 papillary renal cell carcinoma WP4241,0.3803471426204138,1.415193912616593,1.368026787431211,"['ELOB', 'ELOC', 'RBX1']",0.9997651170634212,0,0,3
139,PPAR signaling pathway WP3942,0.3806983996217492,1.320951562052164,1.2757060905590534,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.9997651170634212,0,0,4
140,Acetylcholine Synthesis WP528,0.3820022032728354,2.47598627787307,2.382713157792404,['PDHA1'],0.9997651170634212,0,0,1
141,Alanine and aspartate metabolism WP106,0.3820022032728354,2.47598627787307,2.382713157792404,['GOT1'],0.9997651170634212,0,0,1
142,"Degradation pathway of sphingolipids, including diseases WP4153",0.3820022032728354,2.47598627787307,2.382713157792404,['GM2A'],0.9997651170634212,0,0,1
143,Glial Cell Differentiation WP2276,0.3820022032728354,2.47598627787307,2.382713157792404,['GAP43'],0.9997651170634212,0,0,1
144,let-7 inhibition of ES cell reprogramming WP3299,0.3820022032728354,2.47598627787307,2.382713157792404,['TRIM71'],0.9997651170634212,0,0,1
145,Molybdenum cofactor (Moco) biosynthesis WP4507,0.3820022032728354,2.47598627787307,2.382713157792404,['MOCS2'],0.9997651170634212,0,0,1
146,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.3820022032728354,2.47598627787307,2.382713157792404,['MEF2D'],0.9997651170634212,0,0,1
147,Cell cycle WP179,0.3912392409241293,1.1582329587510936,1.086927547433569,"['CDKN2D', 'CCNB1', 'CCND1', 'YWHAQ', 'GADD45A', 'SKP1', 'RBX1', 'ANAPC11', 'YWHAH']",0.9997651170634212,0,0,9
148,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.40219629002433316,1.2782292735694671,1.1642304289022944,"['TKFC', 'IRF3', 'PIN1', 'IKBKG']",0.9997651170634212,0,0,4
149,TNF-alpha signaling pathway WP231,0.40293787865700204,1.1754967855055523,1.0684946940501117,"['BAD', 'BAX', 'KRAS', 'IKBKG', 'TXN', 'HRAS', 'SKP1']",0.9997651170634212,0,0,7
150,ATM Signaling Pathway WP2516,0.40603323229769367,1.3507497656982193,1.2174581432246474,"['CCNB1', 'GADD45A', 'IKBKG']",0.9997651170634212,0,0,3
151,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.40603323229769367,1.3507497656982193,1.2174581432246474,"['MAP1LC3A', 'ATG101', 'FTL']",0.9997651170634212,0,0,3
152,p38 MAPK Signaling Pathway WP400,0.40603323229769367,1.3507497656982193,1.2174581432246474,"['DDIT3', 'HRAS', 'MEF2D']",0.9997651170634212,0,0,3
153,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.40603323229769367,1.3507497656982193,1.2174581432246474,"['STAR', 'CALM3', 'CALM2']",0.9997651170634212,0,0,3
154,IL-7 signaling pathway WP205,0.4062382303936419,1.5238032353912183,1.3726655994424044,"['CCND1', 'BAD']",0.9997651170634212,0,0,2
155,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.4062382303936419,1.5238032353912183,1.3726655994424044,"['CCND1', 'ICAM1']",0.9997651170634212,0,0,2
156,"Relationship between inflammation, COX-2 and EGFR WP4483",0.4062382303936419,1.5238032353912183,1.3726655994424044,"['KRAS', 'HRAS']",0.9997651170634212,0,0,2
157,TLR4 Signaling and Tolerance WP3851,0.4062382303936419,1.5238032353912183,1.3726655994424044,"['IRF3', 'IKBKG']",0.9997651170634212,0,0,2
158,22q11.2 copy number variation syndrome WP4657,0.4184290537439642,1.1558045977011495,1.0069923615298486,"['RANBP1', 'MRPL40', 'DGCR6L', 'EMC10', 'RAN', 'RBX1', 'PAK4']",0.9997651170634212,0,0,7
159,TGF-beta Signaling Pathway WP366,0.43167777104264876,1.1145077720207255,0.9362710855605078,"['MAP4K1', 'KLF6', 'PARD6A', 'CCND1', 'CITED1', 'SUMO1', 'STRAP', 'SKP1', 'RBX1']",0.9997651170634212,0,0,9
160,Acute viral myocarditis WP4298,0.43486537969668576,1.1792066224079993,0.9819474855359084,"['ENDOG', 'CCND1', 'RAC3', 'CYCS', 'BAX']",0.9997651170634212,0,0,5
161,Canonical NF-KB pathway WP4562,0.43872724735225416,1.9806174957118354,1.6317859203369887,['IKBKG'],0.9997651170634212,0,0,1
162,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.43872724735225416,1.9806174957118354,1.6317859203369887,['IKBKG'],0.9997651170634212,0,0,1
163,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.43908478743301815,1.4148375229920294,1.16450005808395,"['H3F3B', 'H2AFZ']",0.9997651170634212,0,0,2
164,miRNAs involvement in the immune response in sepsis WP4329,0.43908478743301815,1.4148375229920294,1.16450005808395,"['IKBKG', 'ICAM1']",0.9997651170634212,0,0,2
165,Striated Muscle Contraction Pathway WP383,0.43908478743301815,1.4148375229920294,1.16450005808395,"['TPM3', 'ACTG1']",0.9997651170634212,0,0,2
166,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.456346190086114,1.2379725085910653,0.9711938509674924,"['NDUFA13', 'COPS6', 'IKBKG']",0.9997651170634212,0,0,3
167,PDGF Pathway WP2526,0.456346190086114,1.2379725085910653,0.9711938509674924,"['PAK1', 'ARFIP2', 'HRAS']",0.9997651170634212,0,0,3
168,Regulation of Microtubule Cytoskeleton WP2038,0.456346190086114,1.2379725085910653,0.9711938509674924,"['PAK1', 'PARD6A', 'CFL2']",0.9997651170634212,0,0,3
169,Small cell lung cancer WP4658,0.46459652841553556,1.100478927203065,0.843611662817718,"['CCND1', 'GADD45A', 'CYCS', 'BAX', 'IKBKG', 'CKS1B', 'SKP1']",0.9997651170634212,0,0,7
170,Genotoxicity pathway WP4286,0.46563399535649475,1.1651408628799758,0.8905816766868943,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1']",0.9997651170634212,0,0,4
171,Prader-Willi and Angelman Syndrome WP3998,0.46563399535649475,1.1651408628799758,0.8905816766868943,"['GABRB3', 'POMC', 'CCND1', 'FEZ1']",0.9997651170634212,0,0,4
172,Intraflagellar transport proteins binding to dynein WP4532,0.47090791086029304,1.3204005722460659,0.9943840616446467,"['IFT22', 'DYNLL1']",0.9997651170634212,0,0,2
173,White fat cell differentiation WP4149,0.47090791086029304,1.3204005722460659,0.9943840616446467,"['IRF3', 'DDIT3']",0.9997651170634212,0,0,2
174,G1 to S cell cycle control WP45,0.4717690553530792,1.1254107338444688,0.8454824857246976,"['CDKN2D', 'CCNB1', 'CCND1', 'GADD45A', 'RPA2']",0.9997651170634212,0,0,5
175,G13 Signaling Pathway WP524,0.48082431174631485,1.1883505154639176,0.8701736243462199,"['CFL2', 'ARHGDIB', 'CALM2']",0.9997651170634212,0,0,3
176,Glycogen Synthesis and Degradation WP500,0.48082431174631485,1.1883505154639176,0.8701736243462199,"['UGP2', 'CALM3', 'CALM2']",0.9997651170634212,0,0,3
177,Histone Modifications WP2369,0.48082431174631485,1.1883505154639176,0.8701736243462199,"['SET', 'H3F3B', 'SETD9']",0.9997651170634212,0,0,3
178,Sleep regulation WP3591,0.48082431174631485,1.1883505154639176,0.8701736243462199,"['AHCY', 'STAR', 'CRH']",0.9997651170634212,0,0,3
179,ACE Inhibitor Pathway WP554,0.4902496299345485,1.6503716409376787,1.1764518591855369,['MAS1'],0.9997651170634212,0,0,1
180,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.4902496299345485,1.6503716409376787,1.1764518591855369,['NSDHL'],0.9997651170634212,0,0,1
181,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.4902496299345485,1.6503716409376787,1.1764518591855369,['STAR'],0.9997651170634212,0,0,1
182,Cytosine methylation WP3585,0.4902496299345485,1.6503716409376787,1.1764518591855369,['TDG'],0.9997651170634212,0,0,1
183,Insulin signaling in adipocytes (diabetic condition) WP3635,0.4902496299345485,1.6503716409376787,1.1764518591855369,['RPS6'],0.9997651170634212,0,0,1
184,Insulin signaling in adipocytes (normal condition) WP3634,0.4902496299345485,1.6503716409376787,1.1764518591855369,['RPS6'],0.9997651170634212,0,0,1
185,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.4902496299345485,1.6503716409376787,1.1764518591855369,['ELL'],0.9997651170634212,0,0,1
186,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.4902496299345485,1.6503716409376787,1.1764518591855369,['SQSTM1'],0.9997651170634212,0,0,1
187,Iron metabolism in placenta WP2007,0.4902496299345485,1.6503716409376787,1.1764518591855369,['FTH1'],0.9997651170634212,0,0,1
188,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.4902496299345485,1.6503716409376787,1.1764518591855369,['BAX'],0.9997651170634212,0,0,1
189,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.4902496299345485,1.6503716409376787,1.1764518591855369,['AHCY'],0.9997651170634212,0,0,1
190,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.4902496299345485,1.6503716409376787,1.1764518591855369,['VEGFB'],0.9997651170634212,0,0,1
191,NLR Proteins WP288,0.4902496299345485,1.6503716409376787,1.1764518591855369,['IKBKG'],0.9997651170634212,0,0,1
192,Purine metabolism WP4792,0.4902496299345485,1.6503716409376787,1.1764518591855369,['APRT'],0.9997651170634212,0,0,1
193,Role of Osx and miRNAs in tooth development WP3971,0.4902496299345485,1.6503716409376787,1.1764518591855369,['NOTCH4'],0.9997651170634212,0,0,1
194,Supression of HMGB1 mediated inflammation by THBD WP4479,0.4902496299345485,1.6503716409376787,1.1764518591855369,['IKBKG'],0.9997651170634212,0,0,1
195,Thiamine metabolic pathways WP4297,0.4902496299345485,1.6503716409376787,1.1764518591855369,['PDHA1'],0.9997651170634212,0,0,1
196,Fatty acid beta-oxidation WP143,0.5016188085229597,1.2377682403433476,0.853954619703501,"['TPI1', 'DLD']",0.9997651170634212,0,0,2
197,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.5047675678319603,1.1425455987311657,0.7811095447567206,"['STAR', 'KRAS', 'HRAS']",0.9997651170634212,0,0,3
198,Oxidative Damage WP3941,0.5047675678319603,1.1425455987311657,0.7811095447567206,"['BAD', 'GADD45A', 'CYCS']",0.9997651170634212,0,0,3
199,Exercise-induced Circadian Regulation WP410,0.5065592247085989,1.1002197382248973,0.7482748831228895,"['IDI1', 'UGP2', 'SUMO1', 'STBD1']",0.9997651170634212,0,0,4
200,Apoptosis Modulation and Signaling WP1772,0.5249873337018909,1.0422049956933679,0.6715772463273385,"['ENDOG', 'AIFM2', 'BAD', 'TNFRSF10B', 'CYCS', 'BAX']",0.9997651170634212,0,0,6
201,Amino Acid metabolism WP3925,0.5255442529087404,1.053301351301864,0.6776107534433138,"['LDHA', 'PDHA1', 'GOT1', 'ODC1', 'DLD']",0.9997651170634212,0,0,5
202,Proximal tubule transport WP4917,0.5264894848174603,1.0703911133833748,0.6866815024173758,"['ATP6V1G1', 'ATP6V1E1', 'ATP6V1D', 'ATP6V1F']",0.9997651170634212,0,0,4
203,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.5281255016050836,1.1001336387934326,0.7023487820514016,"['BANF1', 'KRAS', 'HRAS']",0.9997651170634212,0,0,3
204,Autophagy WP4923,0.5311535659383256,1.164857359252714,0.7370100249715117,"['MAP1LC3B', 'ATG101']",0.9997651170634212,0,0,2
205,Gastric Cancer Network 2 WP2363,0.5311535659383256,1.164857359252714,0.7370100249715117,"['S100A6', 'COL9A3']",0.9997651170634212,0,0,2
206,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.5311535659383256,1.164857359252714,0.7370100249715117,"['IRF3', 'IKBKG']",0.9997651170634212,0,0,2
207,Toll-like Receptor Signaling related to MyD88 WP3858,0.5311535659383256,1.164857359252714,0.7370100249715117,"['IRF3', 'IKBKG']",0.9997651170634212,0,0,2
208,Type II interferon signaling (IFNG) WP619,0.5311535659383256,1.164857359252714,0.7370100249715117,"['HLA-B', 'ICAM1']",0.9997651170634212,0,0,2
209,Dopamine metabolism WP2436,0.5370461521033041,1.4144817446704239,0.879342625597986,['SOD1'],0.9997651170634212,0,0,1
210,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.5370461521033041,1.4144817446704239,0.879342625597986,['MAP1LC3A'],0.9997651170634212,0,0,1
211,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.5370461521033041,1.4144817446704239,0.879342625597986,['CCND1'],0.9997651170634212,0,0,1
212,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.5370461521033041,1.4144817446704239,0.879342625597986,['DLL3'],0.9997651170634212,0,0,1
213,Vitamin B12 metabolism WP1533,0.5508561156189493,1.0607511045655376,0.6325064051948591,"['SERPINA3', 'ICAM1', 'SOD1']",0.9997651170634212,0,0,3
214,Fluoropyrimidine Activity WP1601,0.559469334919221,1.1000476871721507,0.6388709119297451,"['TDG', 'GGH']",0.9997651170634212,0,0,2
215,Nanoparticle-mediated activation of receptor signaling WP2643,0.559469334919221,1.1000476871721507,0.6388709119297451,"['KRAS', 'HRAS']",0.9997651170634212,0,0,2
216,16p11.2 proximal deletion syndrome WP4949,0.5600218260671322,1.0101338297797604,0.5856549078670897,"['TMEM219', 'SEZ6L2', 'CCT7', 'CDIPT', 'CCT4']",0.9997651170634212,0,0,5
217,Head and Neck Squamous Cell Carcinoma WP4674,0.5600218260671322,1.0101338297797604,0.5856549078670897,"['CCND1', 'SESN1', 'RPS6', 'KRAS', 'HRAS']",0.9997651170634212,0,0,5
218,IL-3 signaling pathway WP286,0.5729252309101688,1.0240846071809455,0.5704151854424092,"['YWHAQ', 'BAD', 'HRAS']",0.9997651170634212,0,0,3
219,Interleukin-11 Signaling Pathway WP2332,0.5729252309101688,1.0240846071809455,0.5704151854424092,"['RPS6', 'HRAS', 'ICAM1']",0.9997651170634212,0,0,3
220,Breast cancer pathway WP4262,0.5751325935668598,0.9788475772931732,0.5414541059165701,"['SHC3', 'CCND1', 'GADD45A', 'NOTCH4', 'BAX', 'KRAS', 'HRAS', 'SKP1', 'DLL3']",0.9997651170634212,0,0,9
221,Cell Differentiation - Index expanded WP2023,0.5795499523062708,1.2375643224699828,0.6750955715429003,['MEF2D'],0.9997651170634212,0,0,1
222,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.5795499523062708,1.2375643224699828,0.6750955715429003,['CCK'],0.9997651170634212,0,0,1
223,Glutathione metabolism WP100,0.5795499523062708,1.2375643224699828,0.6750955715429003,['GPX4'],0.9997651170634212,0,0,1
224,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.5795499523062708,1.2375643224699828,0.6750955715429003,['CCND1'],0.9997651170634212,0,0,1
225,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.5795499523062708,1.2375643224699828,0.6750955715429003,['HMGCS1'],0.9997651170634212,0,0,1
226,Sulfation Biotransformation Reaction WP692,0.5795499523062708,1.2375643224699828,0.6750955715429003,['SULT4A1'],0.9997651170634212,0,0,1
227,Transcription co-factors SKI and SKIL protein partners WP4533,0.5795499523062708,1.2375643224699828,0.6750955715429003,['LATS1'],0.9997651170634212,0,0,1
228,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.5865410115038968,1.0420600858369098,0.5559522769265975,"['RAB3A', 'NEFL']",0.9997651170634212,0,0,2
229,Lipid Metabolism Pathway WP3965,0.5865410115038968,1.0420600858369098,0.5559522769265975,"['PDHA1', 'PRKAR1A']",0.9997651170634212,0,0,2
230,DNA damage response (only ATM dependent) WP710,0.5868487734225193,0.9735248019655187,0.5188771525536727,"['CCND1', 'BAD', 'RAC3', 'BAX', 'KRAS', 'HRAS']",0.9997651170634212,0,0,6
231,Gastrin signaling pathway WP4659,0.5958214162080039,0.9621647509578544,0.4982226612788498,"['PAK1', 'CCND1', 'BAD', 'RPS6', 'KRAS', 'HRAS', 'MEF2D']",0.9997651170634212,0,0,7
232,Pathways in clear cell renal cell carcinoma WP4018,0.6016518125866646,0.9577394348587147,0.4866047902272821,"['LDHA', 'TPI1', 'PGBD5', 'PGK1', 'SQSTM1', 'PFKM']",0.9997651170634212,0,0,6
233,Prolactin Signaling Pathway WP2037,0.6092532977936609,0.9516086323315239,0.4715422263171577,"['PTPN1', 'PAK1', 'RPS6', 'PPIB', 'HRAS']",0.9997651170634212,0,0,5
234,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.6123583454785043,0.9898712446351932,0.48547011316233474,"['IRF3', 'IKBKG']",0.9997651170634212,0,0,2
235,IL-2 signaling pathway WP49,0.6123583454785043,0.9898712446351932,0.48547011316233474,"['RPS6', 'HRAS']",0.9997651170634212,0,0,2
236,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.6123583454785043,0.9898712446351932,0.48547011316233474,"['LATS1', 'YWHAQ']",0.9997651170634212,0,0,2
237,Kit receptor signaling pathway WP304,0.6149775219706011,0.9578483538410376,0.4656767141559044,"['BAD', 'RPS6', 'HRAS']",0.9997651170634212,0,0,3
238,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.6149775219706011,0.9578483538410376,0.4656767141559044,"['HOMER1', 'KRAS', 'HRAS']",0.9997651170634212,0,0,3
239,Integrin-mediated Cell Adhesion WP185,0.6161633827946059,0.942455190517206,0.4563774407918314,"['PAK1', 'SHC3', 'RAC3', 'ITGAE', 'HRAS', 'PAK4']",0.9997651170634212,0,0,6
240,Biomarkers for urea cycle disorders WP4583,0.618154501805212,1.099961882980751,0.5291001999052806,['GOT1'],0.9997651170634212,0,0,1
241,Cells and molecules involved in local acute inflammatory response  WP4493,0.618154501805212,1.099961882980751,0.5291001999052806,['ICAM1'],0.9997651170634212,0,0,1
242,Nanoparticle triggered autophagic cell death WP2509,0.618154501805212,1.099961882980751,0.5291001999052806,['MAP1LC3A'],0.9997651170634212,0,0,1
243,Nanoparticle triggered regulated necrosis WP2513,0.618154501805212,1.099961882980751,0.5291001999052806,['FTL'],0.9997651170634212,0,0,1
244,Osteoclast Signaling WP12,0.618154501805212,1.099961882980751,0.5291001999052806,['ATP6V1G1'],0.9997651170634212,0,0,1
245,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.618154501805212,1.099961882980751,0.5291001999052806,['ANAPC11'],0.9997651170634212,0,0,1
246,SARS coronavirus and innate immunity WP4912,0.618154501805212,1.099961882980751,0.5291001999052806,['IRF3'],0.9997651170634212,0,0,1
247,Serotonin and anxiety-related events WP3944,0.618154501805212,1.099961882980751,0.5291001999052806,['CRH'],0.9997651170634212,0,0,1
248,Notch Signaling WP268,0.6349257466341414,0.9278350515463918,0.4214664940465044,"['NOTCH4', 'DTX3', 'DLL3']",0.9997651170634212,0,0,3
249,Aryl Hydrocarbon Receptor Pathway WP2873,0.6369234298837155,0.9426527692622113,0.42523616449813695,"['AIP', 'BAX']",0.9997651170634212,0,0,2
250,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6369234298837155,0.9426527692622113,0.42523616449813695,"['KRAS', 'HRAS']",0.9997651170634212,0,0,2
251,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6369234298837155,0.9426527692622113,0.42523616449813695,"['IFITM3', 'DDIT3']",0.9997651170634212,0,0,2
252,IL-5 signaling pathway WP127,0.6369234298837155,0.9426527692622113,0.42523616449813695,"['RPS6', 'KRAS']",0.9997651170634212,0,0,2
253,Complement system WP2806,0.6402355859734379,0.91620450054185,0.40855305631774885,"['FCGR3A', 'RPS19', 'CD59', 'TXN', 'ICAM1']",0.9997651170634212,0,0,5
254,Hepatitis B infection WP4666,0.6410762635761151,0.9202801131689308,0.4091628451792826,"['YWHAQ', 'IRF3', 'BAD', 'CYCS', 'BAX', 'KRAS', 'IKBKG', 'HRAS']",0.9997651170634212,0,0,8
255,ERK Pathway in Huntington's Disease WP3853,0.6532172342249315,0.9898799313893654,0.4215359479126834,['HRAS'],0.9997651170634212,0,0,1
256,Genes targeted by miRNAs in adipocytes WP1992,0.6532172342249315,0.9898799313893654,0.4215359479126834,['TMSB4X'],0.9997651170634212,0,0,1
257,Hedgehog Signaling Pathway Netpath WP47,0.6532172342249315,0.9898799313893654,0.4215359479126834,['SAP18'],0.9997651170634212,0,0,1
258,Platelet-mediated interactions with vascular and circulating cells WP4462,0.6532172342249315,0.9898799313893654,0.4215359479126834,['ICAM1'],0.9997651170634212,0,0,1
259,Purine metabolism and related disorders WP4224,0.6532172342249315,0.9898799313893654,0.4215359479126834,['APRT'],0.9997651170634212,0,0,1
260,Transcriptional cascade regulating adipogenesis WP4211,0.6532172342249315,0.9898799313893654,0.4215359479126834,['DDIT3'],0.9997651170634212,0,0,1
261,Insulin Signaling WP481,0.6574209526711531,0.9083747488632758,0.3810002987740318,"['MAP4K1', 'CAP1', 'PTPN1', 'XBP1', 'SHC3', 'STX4', 'HRAS', 'PFKM', 'VAMP2']",0.9997651170634212,0,0,9
262,Neural Crest Cell Migration during Development WP4564,0.6602485258368097,0.8997268825595006,0.37351168279766694,"['PAK1', 'PAK4']",0.9997651170634212,0,0,2
263,Interferon type I signaling pathways WP585,0.6726200526850394,0.87310491206792,0.3462512892657732,"['PTPRC', 'RPS6', 'RACK1']",0.9997651170634212,0,0,3
264,Circadian rhythm related genes WP3594,0.6823655349480993,0.8908562841147111,0.340476175900781,"['RAI1', 'AHCY', 'HOMER1', 'STAR', 'CAVIN3', 'CRH', 'RPS27A', 'UBA52', 'SKP1', 'CIART']",0.9997651170634212,0,0,10
265,Airway smooth muscle cell contraction WP4962,0.6850628438625208,0.8998128800873226,0.34034945474111267,['CALM2'],0.9997651170634212,0,0,1
266,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.6850628438625208,0.8998128800873226,0.34034945474111267,['CCND1'],0.9997651170634212,0,0,1
267,miRNAs involved in DNA damage response WP1545,0.6850628438625208,0.8998128800873226,0.34034945474111267,['CCND1'],0.9997651170634212,0,0,1
268,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6850628438625208,0.8998128800873226,0.34034945474111267,['GOT1'],0.9997651170634212,0,0,1
269,NOTCH1 regulation of endothelial cell calcification WP3413,0.6850628438625208,0.8998128800873226,0.34034945474111267,['DLL3'],0.9997651170634212,0,0,1
270,Overview of nanoparticle effects WP3287,0.6850628438625208,0.8998128800873226,0.34034945474111267,['BAX'],0.9997651170634212,0,0,1
271,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.6850628438625208,0.8998128800873226,0.34034945474111267,['IRF3'],0.9997651170634212,0,0,1
272,EGF/EGFR signaling pathway WP437,0.6897147045142101,0.881162468578464,0.32733180059638584,"['MAP4K1', 'NDUFA13', 'PAK1', 'AP2S1', 'NEDD8', 'KRAS', 'HRAS', 'MEF2D', 'AP2M1']",0.9997651170634212,0,0,9
273,Retinoblastoma gene in cancer WP2446,0.7003989120489298,0.8419165401291597,0.2998108847630097,"['CCNB1', 'CCND1', 'H2AFZ', 'RPA2']",0.9997651170634212,0,0,4
274,Neural Crest Cell Migration in Cancer WP4565,0.7032676122491918,0.8246065808297568,0.29027618442683395,"['PAK1', 'PAK4']",0.9997651170634212,0,0,2
275,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7073699934715754,0.8244558991981672,0.2854278039863344,"['LATS1', 'NABP2', 'BAX']",0.9997651170634212,0,0,3
276,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7073699934715754,0.8244558991981672,0.2854278039863344,"['IFI27L2', 'KRAS', 'HRAS']",0.9997651170634212,0,0,3
277,Apoptosis Modulation by HSP70 WP384,0.7139862822458458,0.824757004002287,0.27785364843525734,['CYCS'],0.9997651170634212,0,0,1
278,IL1 and megakaryocytes in obesity WP2865,0.7139862822458458,0.824757004002287,0.27785364843525734,['ICAM1'],0.9997651170634212,0,0,1
279,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.7139862822458458,0.824757004002287,0.27785364843525734,['CCND1'],0.9997651170634212,0,0,1
280,MAPK pathway in congenital thyroid cancer WP4928,0.7139862822458458,0.824757004002287,0.27785364843525734,['KRAS'],0.9997651170634212,0,0,1
281,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.7139862822458458,0.824757004002287,0.27785364843525734,['LPP'],0.9997651170634212,0,0,1
282,Spinal Cord Injury WP2431,0.7207553175306796,0.8356807511737089,0.2736483122985008,"['BCAN', 'GAP43', 'CCND1', 'GADD45A', 'APEX1', 'ICAM1']",0.9997651170634212,0,0,6
283,B Cell Receptor Signaling Pathway WP23,0.7235562519208741,0.8241537578886976,0.2666771891554639,"['MAP4K1', 'PTPRC', 'IKBKG', 'HRAS', 'MEF2D']",0.9997651170634212,0,0,5
284,T-cell receptor (TCR) signaling pathway WP69,0.7290136992556502,0.8074122168213803,0.255192929914804,"['MAP4K1', 'PAK1', 'IKBKG', 'HRAS']",0.9997651170634212,0,0,4
285,RANKL/RANK signaling pathway WP2018,0.739217367584478,0.7809278350515464,0.2359677034484649,"['IKBKG', 'SQSTM1', 'ICAM1']",0.9997651170634212,0,0,3
286,Cannabinoid receptor signaling WP3869,0.7402554800030078,0.7612481857764877,0.2289529351714068,['PRKAR1A'],0.9997651170634212,0,0,1
287,EPO Receptor Signaling WP581,0.7402554800030078,0.7612481857764877,0.2289529351714068,['PTPRC'],0.9997651170634212,0,0,1
288,Glycerolipids and Glycerophospholipids WP4722,0.7402554800030078,0.7612481857764877,0.2289529351714068,['CDIPT'],0.9997651170634212,0,0,1
289,Glycerophospholipid Biosynthetic Pathway WP2533,0.7402554800030078,0.7612481857764877,0.2289529351714068,['CDIPT'],0.9997651170634212,0,0,1
290,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7402554800030078,0.7612481857764877,0.2289529351714068,['BAX'],0.9997651170634212,0,0,1
291,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.7402554800030078,0.7612481857764877,0.2289529351714068,['CALM2'],0.9997651170634212,0,0,1
292,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.7402554800030078,0.7612481857764877,0.2289529351714068,['CCND1'],0.9997651170634212,0,0,1
293,Mesodermal commitment pathway WP2857,0.7409424890452276,0.8238505747126437,0.24701698739881184,"['TRIM71', 'LATS1', 'CCND1', 'PRKAR1A', 'SESN1', 'NABP2', 'RPL38']",0.9997651170634212,0,0,7
294,Common Pathways Underlying Drug Addiction WP2636,0.7416518178841908,0.7610432485968966,0.22745710083680054,"['CALM2', 'ACTG1']",0.9997651170634212,0,0,2
295,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.7416518178841908,0.7610432485968966,0.22745710083680054,"['CCND1', 'BAX']",0.9997651170634212,0,0,2
296,Rett syndrome causing genes WP4312,0.7416518178841908,0.7610432485968966,0.22745710083680054,"['IMPDH2', 'GPS2']",0.9997651170634212,0,0,2
297,Cardiac Hypertrophic Response WP2795,0.7540786410363755,0.7608379592915675,0.21475307087821952,"['MAP4K1', 'IKBKG', 'CALM2']",0.9997651170634212,0,0,3
298,Fragile X Syndrome  WP4549,0.7544123201786359,0.801592289964383,0.2259017064940425,"['HOMER1', 'PRKAR1A', 'CLTC', 'AP2S1', 'KRAS', 'AP2M1']",0.9997651170634212,0,0,6
299,One-carbon metabolism and related pathways WP3940,0.7591987758377721,0.7327928787156255,0.20187831496030895,"['GPX4', 'SOD1']",0.9997651170634212,0,0,2
300,Ebstein-Barr virus LMP1 signaling WP262,0.7641138209715834,0.7068120558686597,0.19015966984098173,['IKBKG'],0.9997651170634212,0,0,1
301,Pregnane X receptor pathway WP2876,0.7641138209715834,0.7068120558686597,0.19015966984098173,['PSMC5'],0.9997651170634212,0,0,1
302,Vitamin D in inflammatory diseases WP4482,0.7641138209715834,0.7068120558686597,0.19015966984098173,['IKBKG'],0.9997651170634212,0,0,1
303,Ebola Virus Pathway on Host WP4217,0.7649484333151283,0.7908354866494401,0.21190188135843735,"['PAK1', 'IRF3', 'CLTC', 'HLA-B', 'EIF2S1', 'ACTG1']",0.9997651170634212,0,0,6
304,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.7707965683422606,0.7952338485929449,0.20702385963711153,"['PAK1', 'NOTCH4', 'STRAP', 'KRAS', 'HRAS', 'MEF2D', 'DLL3']",0.9997651170634212,0,0,7
305,Chemokine signaling pathway WP3929,0.7850082715288147,0.7701600724856539,0.1864257360022483,"['GNG3', 'PAK1', 'SHC3', 'KRAS', 'IKBKG', 'HRAS']",0.9997651170634212,0,0,6
306,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.7857823889014158,0.6596340766152087,0.15902153818063286,['RPS6'],0.9997651170634212,0,0,1
307,NRF2-ARE regulation WP4357,0.7857823889014158,0.6596340766152087,0.15902153818063286,['RBX1'],0.9997651170634212,0,0,1
308,PDGFR-beta pathway WP3972,0.7857823889014158,0.6596340766152087,0.15902153818063286,['HRAS'],0.9997651170634212,0,0,1
309,Urea cycle and associated pathways WP4595,0.7857823889014158,0.6596340766152087,0.15902153818063286,['GOT1'],0.9997651170634212,0,0,1
310,Urea cycle and metabolism of amino groups WP497,0.7857823889014158,0.6596340766152087,0.15902153818063286,['ODC1'],0.9997651170634212,0,0,1
311,NRF2 pathway WP2884,0.7945383836753307,0.7602199695222951,0.17484601831703409,"['FTH1', 'MGST3', 'PRDX1', 'TXN', 'SQSTM1', 'FTL']",0.9997651170634212,0,0,6
312,Oncostatin M Signaling Pathway WP2374,0.7945904003715369,0.7063082965144821,0.16240041899109398,"['RPS6', 'KRAS', 'HRAS']",0.9997651170634212,0,0,3
313,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8024895650942654,0.7189556788868913,0.1581964387969882,"['POMC', 'BAD', 'RPS6', 'HRAS']",0.9997651170634212,0,0,4
314,Physiological and pathological hypertrophy of the heart WP1528,0.8054620092712381,0.6183533447684391,0.13377409366951043,['CALM2'],0.9997651170634212,0,0,1
315,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.8057630522620705,0.6593419170243204,0.14239514602500297,"['IRF3', 'NUP98']",0.9997651170634212,0,0,2
316,Endochondral Ossification with Skeletal Dysplasias WP4808,0.8067955869565696,0.6898225845121074,0.14809452204841803,"['HMGCS1', 'SLC38A2', 'CALM2']",0.9997651170634212,0,0,3
317,Endochondral Ossification WP474,0.8067955869565696,0.6898225845121074,0.14809452204841803,"['HMGCS1', 'SLC38A2', 'CALM2']",0.9997651170634212,0,0,3
318,Calcium Regulation in the Cardiac Cell WP536,0.8148034680514223,0.7516866566716641,0.1539516950874055,"['RGS4', 'GNG3', 'YWHAQ', 'PRKAR1A', 'CALM3', 'CALM2', 'YWHAH']",0.9997651170634212,0,0,7
319,Focal Adhesion WP306,0.8181099713221389,0.777533534323767,0.156096475494787,"['PAK1', 'SHC3', 'CCND1', 'BAD', 'VEGFB', 'RAC3', 'HRAS', 'MYL12B', 'PAK4', 'ACTG1']",0.9997651170634212,0,0,10
320,Integrated Cancer Pathway WP1971,0.8194054279300713,0.6380174442752319,0.12707794726189195,"['BAD', 'BAX']",0.9997651170634212,0,0,2
321,Thermogenesis WP4321,0.8230754540729905,0.6936084838062482,0.13505070503143957,"['RPS6', 'KRAS', 'HRAS', 'ACTG1']",0.9997651170634212,0,0,4
322,MTHFR deficiency WP4288,0.8233351039499578,0.5819291696095248,0.11312236785532603,['CYCS'],0.9997651170634212,0,0,1
323,Trans-sulfuration and one-carbon metabolism WP2525,0.8233351039499578,0.5819291696095248,0.11312236785532603,['AHCY'],0.9997651170634212,0,0,1
324,Netrin-UNC5B signaling pathway WP4747,0.8321821473831692,0.6180257510729614,0.11353376239029808,"['DAPK1', 'ICAM1']",0.9997651170634212,0,0,2
325,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.8395673767550941,0.5495521250238231,0.09609938187273448,['H3F3B'],0.9997651170634212,0,0,1
326,Estrogen signaling pathway WP712,0.8395673767550941,0.5495521250238231,0.09609938187273448,['IKBKG'],0.9997651170634212,0,0,1
327,One-carbon metabolism WP241,0.8395673767550941,0.5495521250238231,0.09609938187273448,['AHCY'],0.9997651170634212,0,0,1
328,Oxidative Stress WP408,0.8395673767550941,0.5495521250238231,0.09609938187273448,['SOD1'],0.9997651170634212,0,0,1
329,Tumor suppressor activity of SMARCB1 WP4204,0.8395673767550941,0.5495521250238231,0.09609938187273448,['H3F3B'],0.9997651170634212,0,0,1
330,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.8395673767550941,0.5495521250238231,0.09609938187273448,['PPIB'],0.9997651170634212,0,0,1
331,Adipogenesis WP236,0.8465388143071735,0.6860776439089692,0.11430000428931864,"['KLF6', 'GADD45A', 'DDIT3', 'GTF3A', 'MEF2D']",0.9997651170634212,0,0,5
332,7-oxo-C and 7beta-HC pathways WP5064,0.8543093441331477,0.5205831903945112,0.08197202926166652,['THEM5'],0.9997651170634212,0,0,1
333,Ethanol effects on histone modifications WP3996,0.8543093441331477,0.5205831903945112,0.08197202926166652,['AHCY'],0.9997651170634212,0,0,1
334,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.8543093441331477,0.5205831903945112,0.08197202926166652,['GABRB3'],0.9997651170634212,0,0,1
335,Resistin as a regulator of inflammation WP4481,0.8543093441331477,0.5205831903945112,0.08197202926166652,['IKBKG'],0.9997651170634212,0,0,1
336,Metapathway biotransformation Phase I and II WP702,0.8594126490689658,0.6890210924824229,0.10439089114043482,"['AKR7A2', 'AKR7A3', 'GPX4', 'GSTO1', 'MGST3', 'SULT4A1']",0.9997651170634212,0,0,6
337,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.8618504959306256,0.6674187095873843,0.09922745012870837,"['MAP4K1', 'CAP1', 'PTPN1', 'SHC3', 'HRAS']",0.9997651170634212,0,0,5
338,IL-1 signaling pathway WP195,0.8657528337847611,0.5649049662783568,0.08143434004325532,"['IKBKG', 'SQSTM1']",0.9997651170634212,0,0,2
339,Cell migration and invasion through p75NTR WP4561,0.8676977259050423,0.4945111492281304,0.07017700044769169,['PAK1'],0.9997651170634212,0,0,1
340,Heart Development WP1591,0.8676977259050423,0.4945111492281304,0.07017700044769169,['VEGFB'],0.9997651170634212,0,0,1
341,The influence of laminopathies on Wnt signaling WP4844,0.8676977259050423,0.4945111492281304,0.07017700044769169,['CCND1'],0.9997651170634212,0,0,1
342,IL17 signaling pathway WP2112,0.8798567092314349,0.4709221596014049,0.060276254076677964,['IKBKG'],0.9997651170634212,0,0,1
343,Vitamin D-sensitive calcium signaling in depression WP4698,0.8798567092314349,0.4709221596014049,0.060276254076677964,['GPX4'],0.9997651170634212,0,0,1
344,Zinc homeostasis WP3529,0.8798567092314349,0.4709221596014049,0.060276254076677964,['MT3'],0.9997651170634212,0,0,1
345,Target Of Rapamycin (TOR) Signaling WP1471,0.8908990963832368,0.449477623577109,0.05192550041954807,['IDI1'],0.9997651170634212,0,0,1
346,Glioblastoma signaling pathways WP2261,0.8913924103056341,0.5699841395717684,0.06553138024776935,"['CCND1', 'KRAS', 'HRAS']",0.9997651170634212,0,0,3
347,Phosphodiesterases in neuronal function WP4222,0.8930547886283366,0.5201716738197425,0.05883523777128064,"['PDE1C', 'PDE6G']",0.9997651170634212,0,0,2
348,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.9009273476405005,0.4298978298157954,0.04485152426315239,['CCND1'],0.9997651170634212,0,0,1
349,Melatonin metabolism and effects WP3298,0.9009273476405005,0.4298978298157954,0.04485152426315239,['CALM2'],0.9997651170634212,0,0,1
350,3q29 copy number variation syndrome WP4906,0.9009438623644012,0.5067899196654562,0.05286443695401271,"['PIGM', 'DYNLL1']",0.9997651170634212,0,0,2
351,Corticotropin-releasing hormone signaling pathway WP2355,0.9049519504525411,0.5487781596029019,0.0548083571713673,"['POMC', 'STAR', 'CRH']",0.9997651170634212,0,0,3
352,Pathways affected in adenoid cystic carcinoma WP3651,0.9082870987837722,0.4940772532188841,0.047527643916359635,"['BRD1', 'HRAS']",0.9997651170634212,0,0,2
353,Cardiac Progenitor Differentiation WP2406,0.9100345286942474,0.4119496855345912,0.038835624184921244,['MESP1'],0.9997651170634212,0,0,1
354,Disruption of postsynaptic signaling by CNV WP4875,0.9100345286942474,0.4119496855345912,0.038835624184921244,['HOMER1'],0.9997651170634212,0,0,1
355,Microglia Pathogen Phagocytosis Pathway WP3937,0.9100345286942474,0.4119496855345912,0.038835624184921244,['RAC3'],0.9997651170634212,0,0,1
356,Pre-implantation embryo WP3527,0.9100345286942474,0.4119496855345912,0.038835624184921244,['DDIT3'],0.9997651170634212,0,0,1
357,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.9100345286942474,0.4119496855345912,0.038835624184921244,['BAX'],0.9997651170634212,0,0,1
358,Endoderm differentiation WP2853,0.915744864590276,0.5945814238019203,0.05233356167679396,"['TRIM71', 'SESN1', 'TCEAL2', 'NABP2', 'NME1']",0.9997651170634212,0,0,5
359,Alpha 6 Beta 4 signaling pathway WP244,0.9183051713955882,0.39543739279588336,0.033701354617050164,['HRAS'],0.9997651170634212,0,0,1
360,Neovascularisation processes WP4331,0.9183051713955882,0.39543739279588336,0.033701354617050164,['NOTCH4'],0.9997651170634212,0,0,1
361,Oxysterols derived from cholesterol WP4545,0.9183051713955882,0.39543739279588336,0.033701354617050164,['THEM5'],0.9997651170634212,0,0,1
362,AGE/RAGE pathway WP2324,0.9214690673062061,0.4704680155323932,0.0384777301446575,"['CYCS', 'SOD1']",0.9997651170634212,0,0,2
363,Hedgehog Signaling Pathway WP4249,0.9258160558179858,0.38019527642169154,0.02930534084900588,['CCND1'],0.9997651170634212,0,0,1
364,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9258160558179858,0.38019527642169154,0.02930534084900588,['SUPT4H1'],0.9997651170634212,0,0,1
365,Regulation of toll-like receptor signaling pathway WP1449,0.9271629057222924,0.5483901786567307,0.04147255265002598,"['CUEDC2', 'IRF3', 'IKBKG', 'SQSTM1']",0.9997651170634212,0,0,4
366,Energy Metabolism WP1541,0.9326369201976171,0.36608220570484723,0.02553031930588802,['MEF2D'],0.9997651170634212,0,0,1
367,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9326369201976171,0.36608220570484723,0.02553031930588802,['MAP1LC3A'],0.9997651170634212,0,0,1
368,Prostaglandin Synthesis and Regulation WP98,0.9326369201976171,0.36608220570484723,0.02553031930588802,['S100A6'],0.9997651170634212,0,0,1
369,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.932851024585074,0.44900507218103786,0.031210236793485308,"['SFRP2', 'CCND1']",0.9997651170634212,0,0,2
370,Neural Crest Differentiation WP2064,0.936923166910507,0.4936426116838488,0.03216279029420101,"['PRTG', 'NOTCH4', 'DLL3']",0.9997651170634212,0,0,3
371,IL-6 signaling pathway WP364,0.9388311067682382,0.3529772114677775,0.02227980896978694,['BAD'],0.9997651170634212,0,0,1
372,Nuclear Receptors Meta-Pathway WP2882,0.9457533475414125,0.6447932114022079,0.03596235864473249,"['PSMC5', 'CCND1', 'FTH1', 'MGST3', 'PRDX1', 'AIP', 'BAX', 'DBI', 'TXN', 'SQSTM1', 'FTL']",0.9997651170634212,0,0,11
373,Hepatitis C and Hepatocellular Carcinoma WP3646,0.9495642964830457,0.32938822184105204,0.01704651074376476,['CCND1'],0.9997651170634212,0,0,1
374,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9495642964830457,0.32938822184105204,0.01704651074376476,['RPS6'],0.9997651170634212,0,0,1
375,MAPK Signaling Pathway WP382,0.9516424695630078,0.6232836996597486,0.030893600022014373,"['MAP4K1', 'PAK1', 'RRAS', 'GADD45A', 'DDIT3', 'GNA12', 'RAC3', 'KRAS', 'IKBKG', 'HRAS']",0.9997651170634212,0,0,10
376,Wnt signaling WP428,0.9523667608044812,0.46262886597938147,0.02257863207659054,"['SFRP2', 'CCND1', 'PRICKLE2']",0.9997651170634212,0,0,3
377,ATM Signaling Network in Development and Disease  WP3878,0.9542030146263119,0.3187351297515631,0.014941928873151421,['IKBKG'],0.9997651170634212,0,0,1
378,Development of ureteric collection system WP5053,0.9542030146263119,0.3187351297515631,0.014941928873151421,['CCND1'],0.9997651170634212,0,0,1
379,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9548533056542347,0.4030130507138478,0.01861821835988932,"['SFRP2', 'CCND1']",0.9997651170634212,0,0,2
380,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9548533056542347,0.4030130507138478,0.01861821835988932,"['MYO1E', 'YWHAQ']",0.9997651170634212,0,0,2
381,Nephrotic syndrome WP4758,0.9584154080237707,0.30874785591766724,0.013113748692161354,['MYO1E'],0.9997651170634212,0,0,1
382,Toll-like Receptor Signaling Pathway WP75,0.9615595193432982,0.38714129428595473,0.015175479306165487,"['IRF3', 'IKBKG']",0.9997651170634212,0,0,2
383,Phosphoinositides metabolism WP4971,0.9622406276705998,0.2993658714070378,0.01152280999372534,['PIP4P1'],0.9997651170634212,0,0,1
384,TGF-beta Receptor Signaling WP560,0.9622406276705998,0.2993658714070378,0.01152280999372534,['HRAS'],0.9997651170634212,0,0,1
385,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9632494308878756,0.5081445073371542,0.019026397012695397,"['YWHAQ', 'PRKAR1A', 'SLC25A4', 'VAMP2', 'YWHAH']",0.9997651170634212,0,0,5
386,DNA IR-damage and cellular response via ATR WP4016,0.9645432507821351,0.37966325519973587,0.013706073187660275,"['RPA2', 'IKBKG']",0.9997651170634212,0,0,2
387,IL-4 signaling pathway WP395,0.9657142318825938,0.29053576833821004,0.010136012794206981,['BAD'],0.9997651170634212,0,0,1
388,Complement and Coagulation Cascades WP558,0.9688685159602843,0.2822102425876011,0.008925284630315585,['CLTC'],0.9997651170634212,0,0,1
389,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9688685159602843,0.2822102425876011,0.008925284630315585,['RPS6'],0.9997651170634212,0,0,1
390,Wnt Signaling Pathway WP363,0.9688685159602843,0.2822102425876011,0.008925284630315585,['CCND1'],0.9997651170634212,0,0,1
391,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9717328111376833,0.27434724604535926,0.007866742115216955,['HRAS'],0.9997651170634212,0,0,1
392,Vitamin D Receptor Pathway WP2877,0.9725220910463821,0.4532471511449778,0.012628593318244407,"['CDKN2D', 'CCND1', 'GADD45A', 'S100A6']",0.9997651170634212,0,0,4
393,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9743979057693208,0.3524218270999387,0.009140247320622267,"['IKBKG', 'CALM2']",0.9997651170634212,0,0,2
394,Allograft Rejection WP2328,0.9766955464666088,0.25986277873070324,0.006127641323781396,['HLA-B'],0.9997651170634212,0,0,1
395,MECP2 and Associated Rett Syndrome WP3584,0.9841614422365986,0.23503226333415012,0.003752367192066132,['RPS6'],0.9997651170634212,0,0,1
396,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9869604565353141,0.5339897035060689,0.007008777539465355,"['GNG3', 'RAB14', 'CAB39L', 'BAD', 'RPS6', 'VEGFB', 'KRAS', 'IKBKG', 'ITGAE', 'HRAS']",0.9997651170634212,0,0,10
397,Pathways Regulating Hippo Signaling WP4540,0.9878487517910068,0.30338725652030374,0.003709114963581677,"['LATS1', 'PRKAR1A']",0.9997651170634212,0,0,2
398,AMP-activated protein kinase (AMPK) signaling WP1403,0.9892366443628275,0.21452009844134537,0.0023214720588169385,['CCNB1'],0.9997651170634212,0,0,1
399,Genes related to primary cilium development (based on CRISPR) WP4536,0.9897244596624432,0.29427967458843124,0.00303952593520822,"['TRAF3IP1', 'DYNLL1']",0.9997651170634212,0,0,2
400,Ectoderm Differentiation WP2858,0.9919804920665019,0.33575445173383317,0.0027034401664625613,"['KCNK10', 'CELSR2', 'LY6E']",0.9997651170634212,0,0,3
401,Osteoblast differentiation WP4787,0.9926663747324084,0.27760382034697456,0.0020433441430708073,"['NOTCH4', 'DLL3']",0.9997651170634212,0,0,2
402,Regulatory circuits of the STAT3 signaling pathway WP4538,0.993359761639,0.19340463458110516,0.001288535716264738,['PTPRC'],0.9997651170634212,0,0,1
403,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9939712826785005,0.18966882174429345,0.0011469204248018457,['ACTG1'],0.9997651170634212,0,0,1
404,"GPCRs, Other WP117",0.9950306128058255,0.1826122863858713,0.0009097334431336162,['CELSR2'],0.9997651170634212,0,0,1
405,Joubert Syndrome WP4656,0.9969346364455494,0.16706398813850046,0.000512898372725949,['PDE6G'],0.9997651170634212,0,0,1
406,Wnt signaling pathway and pluripotency WP399,0.997473299108069,0.16155836121811995,0.00040872623758818246,['CCND1'],0.9997651170634212,0,0,1
407,PI3K-Akt signaling pathway WP4172,0.9975193136936863,0.4433957351524462,0.0011012922742656332,"['GNG3', 'CCND1', 'BAD', 'RPS6', 'VEGFB', 'COL9A3', 'KRAS', 'IKBKG', 'HRAS']",0.9997651170634212,0,0,9
408,"GPCRs, Class A Rhodopsin-like WP455",0.9984692190741985,0.27057126643336804,0.00041450267112116274,"['MAS1', 'GPR22', 'APLNR']",0.9997651170634212,0,0,3
409,ESC Pluripotency Pathways WP3931,0.9991266749442375,0.1367448065561273,0.00011947484359499654,['HRAS'],0.9997651170634212,0,0,1
410,Ciliopathies WP4803,0.9997651170634212,0.22297719462667917,5.2379690052570634e-05,"['TRAF3IP1', 'NEK2', 'CCNQ']",0.9997651170634212,0,0,3
